rss feeds Last update New treatment approved for rare form of hemophilia, 4 hours ago

Medications news

Added benefit of vedolizumab is not proven

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Oct 23, 2014
popularity not rated yet | comments 0

Seaweed menace may yield new medicines

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

Oct 22, 2014
popularity 5 / 5 (1) | comments 0

Ebola vaccine not before late 2016: GSK researcher

An Ebola vaccine by British pharmaceuticals giant GlaxoSmithKline may not be ready for commercial use until late 2016 and should therefore not be seen as the "primary answer" to the current outbreak, a company researcher ...

Oct 17, 2014
popularity not rated yet | comments 0

Chimerix gets FDA OK to test drug for Ebola

(AP)—A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Oct 17, 2014
popularity 4.5 / 5 (2) | comments 0

More News Stories

FDA weighs removing bolded warning from Chantix

(AP)—The Food and Drug Administration will ask a panel of experts later this week whether a bold-letter warning on the anti-smoking drug Chantix should be removed based on company-supported evidence that the drug does not ...

Six medication myths busted

Can pain relievers really target a specific part of the body? Are generic medicines inferior to their brand-name counterparts? Are natural medicines always safer then prescription drugs? Can you mix alcohol with a prescription ...

Drug-coated balloon catheter approved

(HealthDay)—The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been approved by the U.S. Food and Drug Administration.

Specialty drugs may be worth the higher costs

(HealthDay)—Despite high costs, specialty drugs may provide value that balances the price difference compared with traditional drugs, according to research published in the October issue of Health Affairs.

Other Spotlight Stories

Find more Medications news articles via sort by date page